臍帯血バンキング市場：保管場所別、用途別-2025-2030年の世界予測

臍帯血バンキング市場は、2023年に283億4,000万米ドルと評価され、2024年には330億8,000万米ドルに達すると予測され、CAGR 16.80％で成長し、2030年には840億8,000万米ドルに達すると予測されています。

臍帯血バンキング市場には、血液疾患、遺伝性疾患、免疫疾患を含む様々な病状の治療に有益な造血幹細胞の豊富な供給源である臍帯血の収集、保管、保存が含まれます。臍帯血バンキングの必要性は、骨髄移植に代わる幹細胞の供給源として、容易に入手でき、より侵襲性の低い供給源となる可能性から浮かび上がってくる。白血病や貧血などの血液疾患の治療や、再生医療への応用が期待されています。最終用途は、病院、研究機関、臍帯血バンクなど多岐にわたる。主な成長要因としては、幹細胞治療の利点に関する意識の高まり、再生医療の進歩、臍帯血バンク構想に対する政府の支援などが挙げられます。公営臍帯血バンクの拡大、自動化やAI統合による保管技術の強化には機が熟しています。とはいえ、高コスト、プライベートバンキングに関する倫理的問題、認知度の低さといった課題が市場の成長を制限しています。技術革新の道筋としては、幹細胞抽出技術の向上、凍結保存技術の改善、非侵襲的採取法の開発などが挙げられます。幹細胞の適合性を高め、治療への応用を拡大するための調査によって、さらなる可能性が開花する可能性があります。市場は競争的であり、技術革新と経営効率を追求する民間企業や公的機関が存在します。研究や技術開発のための戦略的パートナーシップに参加することは、成長を促進する可能性があります。企業は、知識の障壁を克服するための潜在的ドナーの教育、技術改善によるコスト削減、有利な規制政策の提唱に注力すべきです。全体として、この市場には、倫理的・物流的な複雑さを乗り切るための積極的な戦略が求められる一方、技術的進歩を活用してサービスの提供と患者アクセスを拡大することも必要です。

市場力学：急速に進化する臍帯血バンキング市場の主要市場インサイトを公開

臍帯血バンキング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の増加による成長
  • 再生医療への投資
  • 遺伝病治療における臍帯血と幹細胞の用途の増加
• 市場抑制要因
  • 臍帯血の保管、採取にかかるコストの高さ、プライベートバンクに保管された臍帯血が使用できないリスク
• 市場機会
  • 各国政府によるイニシアチブの高まりと資金援助
  • 臍帯血バンクにおける新たな開発・発売
• 市場の課題
  • 臍帯血バンキングに関連する倫理的懸念

ポーターの5つの力：臍帯血バンキング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臍帯血バンキング市場における外部からの影響の把握

外部マクロ環境要因は、臍帯血バンキング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析臍帯血バンキング市場における競合情勢の把握

臍帯血バンキング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス臍帯血バンキング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臍帯血バンキング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨臍帯血バンキング市場における成功への道筋を描く

臍帯血バンキング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加により増加
    • 再生医療への投資
    • 遺伝性疾患治療における臍帯血と幹細胞の応用増加
  • 抑制要因
    • 保管、回収にかかるコストが高く、民間銀行に保管されたユニットが使用できなくなるリスクがある
  • 機会
    • 経済における政府の取り組みと資金の増加
    • 臍帯血バンキングにおける新たな展開と開始
  • 課題
    • 臍帯血バンキングに関連する倫理的な懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 臍帯血バンキング市場ストレージ

• 民間臍帯血バンク
• 公立臍帯血バンク

第7章 臍帯血バンキング市場：用途別

• 骨髄不全症候群
• 免疫不全
• 白血病
• リンパ腫
• 代謝障害

第8章 南北アメリカの臍帯血バンキング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の臍帯血バンキング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの臍帯血バンキング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amag Pharmaceuticals, Inc.
• Americord Registry LLC
• Cord Blood Registry Systems, Inc.
• Cordlife Group
• Cryo-Cell International, Inc.
• LifeCell
• Perkinelmer, Inc.
• Smart Cells International Ltd.
• StemCyte Inc.
• Vita 34 International AG

LIST OF FIGURES

• FIGURE 1. UMBILICAL CORD BLOOD BANKING MARKET RESEARCH PROCESS
• FIGURE 2. UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UMBILICAL CORD BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. UMBILICAL CORD BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. UMBILICAL CORD BLOOD BANKING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. UMBILICAL CORD BLOOD BANKING MARKET DYNAMICS
• TABLE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 24. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 36. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 38. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 73. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. POLAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 81. POLAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. QATAR UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 83. QATAR UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. UMBILICAL CORD BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. UMBILICAL CORD BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023

The Umbilical Cord Blood Banking Market was valued at USD 28.34 billion in 2023, expected to reach USD 33.08 billion in 2024, and is projected to grow at a CAGR of 16.80%, to USD 84.08 billion by 2030.

The umbilical cord blood banking market involves the collection, storage, and preservation of umbilical cord blood, a rich source of hematopoietic stem cells beneficial for treating a variety of medical conditions, including hematological, genetic, and immunological diseases. The necessity of umbilical cord blood banking emerges from its potential to serve as an alternative to bone marrow transplants, providing a readily available, less invasive source of stem cells. Applications include treating blood disorders like leukemia and anemia and exploring regenerative medicine uses. End-use scope spans hospitals, research institutes, and specialized cord blood banks. Key growth factors include increasing awareness about stem cell therapy benefits, advancements in regenerative medicine, and government support for cord blood banking initiatives. Opportunities are ripe in expanding public cord blood banks and enhancing storage technology through automation and AI integration. Nevertheless, challenges like high costs, ethical issues concerning private banking, and a lack of widespread awareness limit market growth. Innovation avenues include enhancing stem cell extraction techniques, improving cryopreservation technology, and developing non-invasive collection methods. Research into increasing stem cell compatibility and expanding treatment applications could unlock further potential. The market is competitive, characterized by private and public entities striving for technological innovation and operational efficiency. Engagement in strategic partnerships for research and technology development could facilitate growth. Companies should focus on educating potential donors to overcome knowledge barriers, reducing costs through technological improvements, and advocating for favorable regulatory policies. Overall, the market demands proactive strategies to navigate ethical and logistical complexities while leveraging technological advancements to expand service offerings and patient access.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Umbilical Cord Blood Banking Market

The Umbilical Cord Blood Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing due to the increasing prevalence of chronic diseases
  • Investments in regenerative medicines
  • Rising applications of cord blood and stem cells in genetic disease treatment
• Market Restraints
  • High cost of storage, collection, and risk of non-usability of the unit stored with a private bank
• Market Opportunities
  • Rising government initiatives and funding in economies
  • New developments and launches in the cord blood banking
• Market Challenges
  • Ethical concerns associated with umbilical cord blood banking

Porter's Five Forces: A Strategic Tool for Navigating the Umbilical Cord Blood Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Umbilical Cord Blood Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Umbilical Cord Blood Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Umbilical Cord Blood Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Umbilical Cord Blood Banking Market

A detailed market share analysis in the Umbilical Cord Blood Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Umbilical Cord Blood Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Umbilical Cord Blood Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Umbilical Cord Blood Banking Market

A strategic analysis of the Umbilical Cord Blood Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Umbilical Cord Blood Banking Market, highlighting leading vendors and their innovative profiles. These include Amag Pharmaceuticals, Inc., Americord Registry LLC, Cord Blood Registry Systems, Inc., Cordlife Group, Cryo-Cell International, Inc., LifeCell, Perkinelmer, Inc., Smart Cells International Ltd., StemCyte Inc., and Vita 34 International AG.

Market Segmentation & Coverage

This research report categorizes the Umbilical Cord Blood Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Storage, market is studied across Private Cord Blood Banks and Public Cord Blood Banks.
• Based on Application, market is studied across Bone Marrow Failure Syndrome, Immune Deficiencies, Leukemia, Lymphoma, and Metabolic Disorder.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing due to the increasing prevalence of chronic diseases
    • 5.1.1.2. Investments in regenerative medicines
    • 5.1.1.3. Rising applications of cord blood and stem cells in genetic disease treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of storage, collection, and risk of non-usability of the unit stored with a private bank
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising government initiatives and funding in economies
    • 5.1.3.2. New developments and launches in the cord blood banking
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns associated with umbilical cord blood banking
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Umbilical Cord Blood Banking Market, by Storage

• 6.1. Introduction
• 6.2. Private Cord Blood Banks
• 6.3. Public Cord Blood Banks

7. Umbilical Cord Blood Banking Market, by Application

• 7.1. Introduction
• 7.2. Bone Marrow Failure Syndrome
• 7.3. Immune Deficiencies
• 7.4. Leukemia
• 7.5. Lymphoma
• 7.6. Metabolic Disorder

8. Americas Umbilical Cord Blood Banking Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Umbilical Cord Blood Banking Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Umbilical Cord Blood Banking Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amag Pharmaceuticals, Inc.
• 2. Americord Registry LLC
• 3. Cord Blood Registry Systems, Inc.
• 4. Cordlife Group
• 5. Cryo-Cell International, Inc.
• 6. LifeCell
• 7. Perkinelmer, Inc.
• 8. Smart Cells International Ltd.
• 9. StemCyte Inc.
• 10. Vita 34 International AG